Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2015

01.12.2015 | Gynecologic Oncology

Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer

verfasst von: Christina Fotopoulou, Ahmed El-Balat, Andreas du Bois, Jalid Sehouli, Philipp Harter, Mustafa Z. Muallem, Robert W. Krätschell, Alexander Traut, Florian Heitz

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients with high-risk early or advanced endometrial cancer (EC) are at high risk for lymph node (LN) metastases. However, both the anatomical pattern of the LN metastases and also the therapeutic value of systematic LN dissection remain a field of discussion and controversy.

Methods

We performed an exploratory analysis of patients with high-risk or advanced EC who underwent systematic pelvic and para-aortic lymphadenectomy in two tertiary referral centers for gynecological malignancies.

Results

One hundred and twenty-eight completely surgically staged patients underwent systematic pelvic and para-aortic lymphadenectomy for high-risk or advanced EC. A median of 29 and 21.5 LN was harvested in the pelvis and in the para-aortic region, respectively. Overall, 27 patients (21.1 %) had positive LN: 18 % showed positive pelvic LN and 14.8 % positive para-aortic LN; while 3.1 % showed isolated para-aortic LN metastases. Five-year overall survival was 70 versus 30 % in LN-negative versus LN-positive patients (p < 0.01). LN-status was the only factor significantly associated with overall survival [HR: 3.67 (95 % CI 1.48–9.11); p = 0.01] in a multivariate Cox regression model.

Conclusions

Patients with high-risk or advanced EC were at a high-risk for LN metastases. Anatomical distribution of positive LN indicates that lymphadenectomy, when performed, should contain both pelvic and para-aortic areas up to the renal vessels for an accurate assessment of all potential positive LN.
Literatur
2.
Zurück zum Zitat Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD et al (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40(1):55–65 PubMed PMID: 1989916. Epub 1991/01/01. eng CrossRefPubMed Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD et al (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40(1):55–65 PubMed PMID: 1989916. Epub 1991/01/01. eng CrossRefPubMed
3.
Zurück zum Zitat Fujimoto T, Nanjyo H, Nakamura A, Yokoyama Y, Takano T, Shoji T et al (2007) Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecol Oncol 107(2):253–259 PubMed PMID: 17640720. Epub 2007/07/21. eng CrossRefPubMed Fujimoto T, Nanjyo H, Nakamura A, Yokoyama Y, Takano T, Shoji T et al (2007) Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecol Oncol 107(2):253–259 PubMed PMID: 17640720. Epub 2007/07/21. eng CrossRefPubMed
4.
Zurück zum Zitat Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707–1716 PubMed PMID: 19033573. Epub 2008/11/27. eng CrossRefPubMed Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707–1716 PubMed PMID: 19033573. Epub 2008/11/27. eng CrossRefPubMed
5.
Zurück zum Zitat Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136 PubMed PMID: 19070889. Pubmed Central PMCID: 2646126. Epub 2008/12/17. eng CrossRefPubMed Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136 PubMed PMID: 19070889. Pubmed Central PMCID: 2646126. Epub 2008/12/17. eng CrossRefPubMed
6.
Zurück zum Zitat Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23(16):3668–3675 PubMed PMID: 15738538. Epub 2005/03/02. eng CrossRefPubMed Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23(16):3668–3675 PubMed PMID: 15738538. Epub 2005/03/02. eng CrossRefPubMed
7.
Zurück zum Zitat Bassarak N, Blankenstein T, Brüning A, Dian D, Bergauer F, Friese K et al (2010) Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium? BMC Cancer 10:224 PubMed PMID: 20492712. Pubmed Central PMCID: 2891635. Epub 2010/05/25. eng PubMedCentralCrossRefPubMed Bassarak N, Blankenstein T, Brüning A, Dian D, Bergauer F, Friese K et al (2010) Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium? BMC Cancer 10:224 PubMed PMID: 20492712. Pubmed Central PMCID: 2891635. Epub 2010/05/25. eng PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375(9721):1165–1172 PubMed PMID: 20188410. Epub 2010/03/02. eng CrossRefPubMed Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375(9721):1165–1172 PubMed PMID: 20188410. Epub 2010/03/02. eng CrossRefPubMed
9.
Zurück zum Zitat Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN et al (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107(8):1823–1830 PubMed PMID: 16977653. Epub 2006/09/16. eng CrossRefPubMed Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN et al (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107(8):1823–1830 PubMed PMID: 16977653. Epub 2006/09/16. eng CrossRefPubMed
10.
Zurück zum Zitat Chang SJ, Kim WY, Yoon JH, Yoo SC, Chang KH, Ryu HS (2008) Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Acta Obstet Gynecol Scand 87(12):1361–1369 PubMed PMID: 18951214. Epub 2008/10/28. eng CrossRefPubMed Chang SJ, Kim WY, Yoon JH, Yoo SC, Chang KH, Ryu HS (2008) Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Acta Obstet Gynecol Scand 87(12):1361–1369 PubMed PMID: 18951214. Epub 2008/10/28. eng CrossRefPubMed
11.
Zurück zum Zitat Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109(1):11–18 PubMed PMID: 18304622. Epub 2008/02/29. eng PubMedCentralCrossRefPubMed Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109(1):11–18 PubMed PMID: 18304622. Epub 2008/02/29. eng PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Eitan R, Abu-Rustum NR, Walker JL, Barakat RR (2004) Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection. Gynecol Oncol 93(1):260–262 PubMed PMID: 15047248. Epub 2004/03/30. eng CrossRefPubMed Eitan R, Abu-Rustum NR, Walker JL, Barakat RR (2004) Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection. Gynecol Oncol 93(1):260–262 PubMed PMID: 15047248. Epub 2004/03/30. eng CrossRefPubMed
13.
Zurück zum Zitat Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ (2003) FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 13(5):664–672 PubMed PMID: 14675352. Epub 2003/12/17. eng CrossRefPubMed Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ (2003) FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 13(5):664–672 PubMed PMID: 14675352. Epub 2003/12/17. eng CrossRefPubMed
14.
Zurück zum Zitat Fotopoulou C, Savvatis K, Kraetschell R, Schefold JC, Lichtenegger W, Sehouli J (2010) Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status. Eur J Obstet Gynecol Reprod Biol 149(2):199–203 PubMed PMID: 20096987. Epub 2010/01/26. eng CrossRefPubMed Fotopoulou C, Savvatis K, Kraetschell R, Schefold JC, Lichtenegger W, Sehouli J (2010) Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status. Eur J Obstet Gynecol Reprod Biol 149(2):199–203 PubMed PMID: 20096987. Epub 2010/01/26. eng CrossRefPubMed
15.
Zurück zum Zitat Amant F, Mirza, Creutzberg CL (2012) Cancer of the corpus uteri. Int J Gynaecol Obstet 119(Suppl 2):S110–S117 PubMed PMID: 22999502. Epub 2012/10/04. eng CrossRefPubMed Amant F, Mirza, Creutzberg CL (2012) Cancer of the corpus uteri. Int J Gynaecol Obstet 119(Suppl 2):S110–S117 PubMed PMID: 22999502. Epub 2012/10/04. eng CrossRefPubMed
16.
Zurück zum Zitat Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A et al (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63(6):825–832 PubMed PMID: 6728365. Epub 1984/06/01. eng PubMed Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A et al (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63(6):825–832 PubMed PMID: 6728365. Epub 1984/06/01. eng PubMed
17.
Zurück zum Zitat Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl):2035–2041 PubMed PMID: 3652025. Epub 1987/10/15. eng CrossRefPubMed Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl):2035–2041 PubMed PMID: 3652025. Epub 1987/10/15. eng CrossRefPubMed
18.
Zurück zum Zitat Mylonas I, Schindlbeck C (2012) Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma. Arch Gynecol Obstet 285(1):207–214CrossRefPubMed Mylonas I, Schindlbeck C (2012) Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma. Arch Gynecol Obstet 285(1):207–214CrossRefPubMed
19.
Zurück zum Zitat Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS (1991) Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78(1):63–69 PubMed PMID: 2047070. Epub 1991/07/01. eng PubMed Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS (1991) Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78(1):63–69 PubMed PMID: 2047070. Epub 1991/07/01. eng PubMed
20.
Zurück zum Zitat Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N (2005) Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 96(3):651–657 PubMed PMID: 15721407. Epub 2005/02/22. eng CrossRefPubMed Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N (2005) Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 96(3):651–657 PubMed PMID: 15721407. Epub 2005/02/22. eng CrossRefPubMed
21.
Zurück zum Zitat Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A et al (2006) Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102(1):92–97 PubMed PMID: 16406063. Epub 2006/01/13. eng CrossRefPubMed Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A et al (2006) Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102(1):92–97 PubMed PMID: 16406063. Epub 2006/01/13. eng CrossRefPubMed
22.
Zurück zum Zitat Mell LK, Carmona R, Gulaya S, Lu T, Wu J, Saenz CC et al (2013) Cause-specific effects of radiotherapy and lymphadenectomy in stage I–II endometrial cancer: a population-based study. J Natl Cancer Inst 105(21):1656–1666CrossRefPubMed Mell LK, Carmona R, Gulaya S, Lu T, Wu J, Saenz CC et al (2013) Cause-specific effects of radiotherapy and lymphadenectomy in stage I–II endometrial cancer: a population-based study. J Natl Cancer Inst 105(21):1656–1666CrossRefPubMed
23.
Zurück zum Zitat Kang S, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM et al (2012) How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study. J Gynecol Oncol 23(4):251–256 PubMed PMID: 23094128. Pubmed Central PMCID: 3469860. Epub 2012/10/25. eng PubMedCentralCrossRefPubMed Kang S, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM et al (2012) How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study. J Gynecol Oncol 23(4):251–256 PubMed PMID: 23094128. Pubmed Central PMCID: 3469860. Epub 2012/10/25. eng PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Abu-Rustum NR, Gomez JD, Alektiar KM, Soslow RA, Hensley ML, Leitao MM Jr et al (2009) The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 115(2):236–238 PubMed PMID: 19666190. Epub 2009/08/12. eng CrossRefPubMed Abu-Rustum NR, Gomez JD, Alektiar KM, Soslow RA, Hensley ML, Leitao MM Jr et al (2009) The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 115(2):236–238 PubMed PMID: 19666190. Epub 2009/08/12. eng CrossRefPubMed
25.
Zurück zum Zitat Chiang AJ, Yu KJ, Chao KC, Teng NN (2011) The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients. Gynecol Oncol 121(1):122–125 PubMed PMID: 21194737. Epub 2011/01/05. eng CrossRefPubMed Chiang AJ, Yu KJ, Chao KC, Teng NN (2011) The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients. Gynecol Oncol 121(1):122–125 PubMed PMID: 21194737. Epub 2011/01/05. eng CrossRefPubMed
26.
Zurück zum Zitat Tanaka H, Sato H, Miura H, Sato N, Fujimoto T, Konishi Y et al (2006) Can we omit para-aorta lymph node dissection in endometrial cancer? Jpn J Clin Oncol 36(9):578–581 PubMed PMID: 16870694. Epub 2006/07/28. eng CrossRefPubMed Tanaka H, Sato H, Miura H, Sato N, Fujimoto T, Konishi Y et al (2006) Can we omit para-aorta lymph node dissection in endometrial cancer? Jpn J Clin Oncol 36(9):578–581 PubMed PMID: 16870694. Epub 2006/07/28. eng CrossRefPubMed
27.
Zurück zum Zitat Lambaudie E, Narducci F, Leblanc E, Bannier M, Jauffret C, Cannone F et al (2012) Robotically assisted laparoscopy for paraaortic lymphadenectomy: technical description and results of an initial experience. Surg Endosc 26(9):2430–2435CrossRefPubMed Lambaudie E, Narducci F, Leblanc E, Bannier M, Jauffret C, Cannone F et al (2012) Robotically assisted laparoscopy for paraaortic lymphadenectomy: technical description and results of an initial experience. Surg Endosc 26(9):2430–2435CrossRefPubMed
28.
Zurück zum Zitat Seamon LG, Cohn DE, Richardson DL, Valmadre S, Carlson MJ, Phillips GS et al (2008) Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer. Obstet Gynecol 112(6):1207–1213CrossRefPubMed Seamon LG, Cohn DE, Richardson DL, Valmadre S, Carlson MJ, Phillips GS et al (2008) Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer. Obstet Gynecol 112(6):1207–1213CrossRefPubMed
29.
Zurück zum Zitat Seamon LG, Cohn DE, Henretta MS, Kim KH, Carlson MJ, Phillips GS et al (2009) Minimally invasive comprehensive surgical staging for endometrial cancer: robotics or laparoscopy? Gynecol Oncol 113(1):36–41CrossRefPubMed Seamon LG, Cohn DE, Henretta MS, Kim KH, Carlson MJ, Phillips GS et al (2009) Minimally invasive comprehensive surgical staging for endometrial cancer: robotics or laparoscopy? Gynecol Oncol 113(1):36–41CrossRefPubMed
30.
Zurück zum Zitat Kuoppala T, Tomas E, Heinonen PK (2004) Clinical outcome and complications of laparoscopic surgery compared with traditional surgery in women with endometrial cancer. Arch Gynecol Obstet 270(1):25–30PubMed Kuoppala T, Tomas E, Heinonen PK (2004) Clinical outcome and complications of laparoscopic surgery compared with traditional surgery in women with endometrial cancer. Arch Gynecol Obstet 270(1):25–30PubMed
31.
Zurück zum Zitat Larson DM, Johnson K, Olson KA (1992) Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol 79(6):998–1001 PubMed PMID: 1579330. Epub 1992/06/01. eng PubMed Larson DM, Johnson K, Olson KA (1992) Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol 79(6):998–1001 PubMed PMID: 1579330. Epub 1992/06/01. eng PubMed
32.
Zurück zum Zitat Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG et al (2006) Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101(2):200–208 PubMed PMID: 16510174. Epub 2006/03/03. eng CrossRefPubMed Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG et al (2006) Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101(2):200–208 PubMed PMID: 16510174. Epub 2006/03/03. eng CrossRefPubMed
33.
Zurück zum Zitat Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al (2011) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22 Suppl 6:vi35–9. PubMed PMID: 21908501 Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al (2011) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22 Suppl 6:vi35–9. PubMed PMID: 21908501
Metadaten
Titel
Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer
verfasst von
Christina Fotopoulou
Ahmed El-Balat
Andreas du Bois
Jalid Sehouli
Philipp Harter
Mustafa Z. Muallem
Robert W. Krätschell
Alexander Traut
Florian Heitz
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-015-3746-6

Weitere Artikel der Ausgabe 6/2015

Archives of Gynecology and Obstetrics 6/2015 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.